Merck & Co., Inc. (MRK) Tops Q3 EPS by 3c
Tweet
Share
E-mailGet Alerts MRK Hot Sheet
Price: $152.55 +2.39%
Financial Fact:
Net Income Attributable to Merck & Co., Inc.: 7.95B
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Net Income Attributable to Merck & Co., Inc.: 7.95B
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Merck & Co., Inc. (NYSE: MRK) reported Q3 EPS of $0.94, $0.03 better than the analyst estimate of $0.91. Revenue for the quarter came in at $12 million versus the consensus estimate of $11.61 billion.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Morgan Stanley Upgrades Merck (MRK) to Overweight
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Nordson Corp. (NDSN) Tops Q3 EPS by 16c; Offers Guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
